Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.2%

1 terminated out of 46 trials

Success Rate

95.5%

+9.0% vs benchmark

Late-Stage Pipeline

15%

7 trials in Phase 3/4

Results Transparency

10%

2 of 21 completed with results

Key Signals

2 with results95% success

Data Visualizations

Phase Distribution

28Total
Not Applicable (5)
P 1 (3)
P 2 (13)
P 3 (7)

Trial Status

Completed21
Unknown19
Recruiting2
Enrolling By Invitation1
Active Not Recruiting1
Suspended1

Trial Success Rate

95.5%

Benchmark: 86.5%

Based on 21 completed trials

Clinical Trials (46)

Showing 20 of 20 trials
NCT02467231Active Not RecruitingPrimary

Ovarian Reserve After Cancer: Longitudinal Effects

NCT05268991CompletedPrimary

Aging and Frailty Study

NCT04544969Recruiting

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

NCT05529940Phase 3Recruiting

NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)

NCT06468943Phase 2Enrolling By InvitationPrimary

Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL

NCT04999332Phase 2Unknown

Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer

NCT02767388Completed

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

NCT05338073Unknown

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

NCT02121405Phase 3Suspended

Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM

NCT01057745TerminatedPrimary

Ovarian Freezing Before Cancer Treatment

NCT01143844CompletedPrimary

Assessing Fertility Potential in Female Cancer Survivors

NCT03197532CompletedPrimary

Assessing Urinary Hormones in Female Cancer Survivors

NCT02375776Not ApplicableCompleted

Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention

NCT03840824Completed

Blood Spot Self-administered Test and Assay

NCT01187212Phase 2Completed

Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE

NCT01993732Not ApplicableCompleted

Ovarian Tissue Cryopreservation in Females Undergoing Procedures That Will Potentially Lead To Loss of Ovarian Function

NCT02087475Phase 3Unknown

Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin

NCT03885388Phase 2Unknown

Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6

NCT03402295Phase 3Completed

Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation

NCT01434394Phase 2Completed

Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer

Scroll to load more

Research Network

Activity Timeline